nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Cefotaxime—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Cefotaxime—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Cefotaxime—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Cefotaxime—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Cefotaxime—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Cefotaxime—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Cefotaxime—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Cefotaxime—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Cefotaxime—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Cefotaxime—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Cefotaxime—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Cefotaxime—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Cefotaxime—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Cefotaxime—Shock—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Cefotaxime—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Cefotaxime—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Cefotaxime—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Cefotaxime—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Cefotaxime—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Cefotaxime—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Cefotaxime—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Cefotaxime—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Cefotaxime—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Cefotaxime—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Cefotaxime—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Cefotaxime—Pain—Topotecan—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Cefotaxime—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Cefotaxime—Pain—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Cefotaxime—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Cefotaxime—Pain—Melphalan—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Cefotaxime—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Cefotaxime—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Cefotaxime—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Cefotaxime—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Cefotaxime—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Cefotaxime—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Cefotaxime—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Cefotaxime—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Cefotaxime—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Cefotaxime—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Cefotaxime—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Cefotaxime—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Cefotaxime—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Cefotaxime—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Cefotaxime—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Cefotaxime—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Cefotaxime—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Cefotaxime—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Cefotaxime—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Cefotaxime—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Cefotaxime—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Cefotaxime—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Cefotaxime—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Cefotaxime—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Cefotaxime—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Cefotaxime—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Cefotaxime—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Cefotaxime—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Cefotaxime—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Cefotaxime—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Cefotaxime—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Cefotaxime—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Cefotaxime—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Cefotaxime—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Cefotaxime—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Cefotaxime—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Cefotaxime—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Cefotaxime—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Cefotaxime—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Cefotaxime—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Cefotaxime—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Cefotaxime—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Cefotaxime—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Cefotaxime—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Cefotaxime—Malaise—Etoposide—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Cefotaxime—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotaxime—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotaxime—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotaxime—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotaxime—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotaxime—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Cefotaxime—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Cefotaxime—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Cefotaxime—Rash—Topotecan—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Cefotaxime—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Cefotaxime—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Cefotaxime—Headache—Topotecan—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Cefotaxime—Rash—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Cefotaxime—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Cefotaxime—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Cefotaxime—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Cefotaxime—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Cefotaxime—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Cefotaxime—Headache—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Cefotaxime—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Cefotaxime—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Cefotaxime—Pain—Vincristine—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Cefotaxime—Rash—Melphalan—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Cefotaxime—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Cefotaxime—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Cefotaxime—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Cefotaxime—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Cefotaxime—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Cefotaxime—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Cefotaxime—Nausea—Topotecan—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Cefotaxime—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Cefotaxime—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Cefotaxime—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Cefotaxime—Nausea—Melphalan—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Cefotaxime—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Cefotaxime—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Cefotaxime—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Cefotaxime—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Cefotaxime—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Cefotaxime—Pain—Cisplatin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Cefotaxime—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Cefotaxime—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Cefotaxime—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Cefotaxime—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Cefotaxime—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Cefotaxime—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Cefotaxime—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Cefotaxime—Pain—Etoposide—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Cefotaxime—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Cefotaxime—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Cefotaxime—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Cefotaxime—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Cefotaxime—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Cefotaxime—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Cefotaxime—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Cefotaxime—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Cefotaxime—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Cefotaxime—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Cefotaxime—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Cefotaxime—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Cefotaxime—Rash—Vincristine—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Cefotaxime—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Cefotaxime—Headache—Vincristine—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Cefotaxime—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Cefotaxime—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Cefotaxime—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Cefotaxime—Nausea—Vincristine—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Cefotaxime—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Cefotaxime—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Cefotaxime—Rash—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Cefotaxime—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Cefotaxime—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Cefotaxime—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Cefotaxime—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Cefotaxime—Rash—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Cefotaxime—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Cefotaxime—Headache—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Cefotaxime—Nausea—Etoposide—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000993	0.000993	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000985	0.000985	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000963	0.000963	CcSEcCtD
Cefotaxime—Shock—Epirubicin—peripheral nervous system neoplasm	0.000948	0.000948	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000946	0.000946	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000891	0.000891	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000877	0.000877	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000873	0.000873	CcSEcCtD
Cefotaxime—Pain—Epirubicin—peripheral nervous system neoplasm	0.000824	0.000824	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000762	0.000762	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000762	0.000762	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000762	0.000762	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000735	0.000735	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.000729	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.000705	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.000705	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000682	0.000682	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.000657	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.000631	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Cefotaxime—Rash—Epirubicin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Cefotaxime—Headache—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
